MARCHETTI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 572
EU - Europa 341
AS - Asia 172
AF - Africa 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.094
Nazione #
US - Stati Uniti d'America 555
IT - Italia 146
CN - Cina 72
SG - Singapore 50
IE - Irlanda 42
FR - Francia 29
GB - Regno Unito 28
IN - India 21
SE - Svezia 16
CA - Canada 14
NL - Olanda 14
VN - Vietnam 12
DE - Germania 8
PL - Polonia 8
GR - Grecia 7
SI - Slovenia 7
BA - Bosnia-Erzegovina 6
ID - Indonesia 5
KR - Corea 5
BE - Belgio 4
RS - Serbia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
ES - Italia 3
HR - Croazia 3
MX - Messico 3
NG - Nigeria 3
AT - Austria 2
BR - Brasile 2
DK - Danimarca 2
EU - Europa 2
FI - Finlandia 2
JP - Giappone 2
ME - Montenegro 2
RO - Romania 2
AR - Argentina 1
GH - Ghana 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
PK - Pakistan 1
TW - Taiwan 1
Totale 1.094
Città #
Santa Clara 81
Chandler 78
Dublin 42
Singapore 42
Fairfield 38
Seattle 26
Ashburn 24
Houston 21
Woodbridge 20
Milan 19
Beijing 16
Cambridge 14
Nyköping 14
Amsterdam 13
Dong Ket 12
Wilmington 12
London 11
Redwood City 11
Torino 11
Pisa 10
Columbus 9
Princeton 9
Rome 9
Medford 8
Mumbai 7
Ann Arbor 6
Banja Luka 6
New York 6
Paris 6
Preveza 6
Turin 6
Chaponost 5
Dearborn 5
Guangzhou 5
Jakarta 5
San Diego 5
Toronto 5
Warsaw 5
Atlanta 4
Belgrade 4
Brookline 4
Hangzhou 4
Newcastle upon Tyne 4
Palermo 4
Vancouver 4
Wuhan 4
Brno 3
Caserta 3
Chengdu 3
Chennai 3
Coyoacán 3
Duncan 3
Genay 3
Hyderabad 3
Kunming 3
Nanjing 3
Napoli 3
Norwalk 3
Philadelphia 3
Seoul 3
Toulouse 3
Villeurbanne 3
Zagreb 3
Abuja 2
Ancona 2
Andover 2
Bambrugge 2
Bengaluru 2
Bergamo 2
Birmingham 2
Boston 2
Celje 2
Clayton 2
Collecchio 2
Dossobuono 2
Flanders 2
Fuzhou 2
Genoa 2
Hebei 2
Jacksonville 2
Kranj 2
Kumar 2
Lake Villa 2
Lenart v Slov. Goricah 2
Madrid 2
Messina 2
New Delhi 2
Nuremberg 2
Padova 2
Phoenix 2
Phoenixville 2
Pomezia 2
Porto Alegre 2
San Francisco 2
Sevenoaks 2
Shenzhen 2
Silver Spring 2
Stockholm 2
Tarbes 2
Vejle 2
Totale 785
Nome #
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 276
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 198
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients. 140
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 135
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 102
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 68
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes 58
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 51
Primary analysis and four-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases 45
Corrigendum: Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study [Front Immunol, 8, (2017), (386)] doi: 10.3389/fimmu.2017.00386 23
Correction: New paradigm for stage III melanoma: From surgery to adjuvant treatment (Journal of Translational Medicine (2019) 17 (266) DOI: 10.1186/s12967-019-2012-2) 17
Totale 1.113
Categoria #
all - tutte 3.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202098 0 0 0 0 0 10 16 16 20 8 14 14
2020/2021129 14 12 13 7 4 19 7 8 10 11 6 18
2021/2022109 7 3 5 6 5 3 2 9 5 5 39 20
2022/2023290 22 25 13 22 20 56 23 27 40 15 15 12
2023/2024193 17 47 16 16 17 21 8 12 1 15 7 16
2024/2025166 3 7 11 17 100 28 0 0 0 0 0 0
Totale 1.113